1. Gut microbiome derived short chain fatty acids: Promising strategies in necrotising enterocolitis.
- Author
-
Cifuentes MP, Chapman JA, and Stewart CJ
- Abstract
Necrotising enterocolitis (NEC) is a devastating condition that poses a significant risk of morbidity and mortality, particularly among preterm babies. Extensive research efforts have been directed at identifying optimal treatment and diagnostic strategies but results from such studies remain unclear and controversial. Among the most promising candidates are prebiotics, probiotics and their metabolites, including short chain fatty acids (SCFAs). Such metabolites have been widely explored as possible biomarkers of gut health for different clinical conditions, with overall positive effects on the host observed. This review aims to describe the role of gut microbiome derived SCFAs in necrotising enterocolitis. Until now, information has been conflicting, with the primary focus on the main three SCFAs (acetic acid, propionic acid, and butyric acid). While numerous studies have indicated the relationship between SCFAs and NEC, the current evidence is insufficient to draw definitive conclusions about the use of these metabolites as NEC biomarkers or their potential in treatment strategies. Ongoing research in this area will help enhance both our understanding of SCFAs as valuable indicators of NEC and their practical application in clinical settings., Competing Interests: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Christopher Stewart reports financial support was provided by Wellcome Trust. Christopher Stewart reports a relationship with Astarte Medical that includes: consulting or advisory. Dr Stewart declares performing consultancy for Astarte Medical and receiving lecture honoraria from Nestle Nutrition Institute. He also supervises a BBSRC collaborative training partnership PhD student for which Nestlé are involved (no salary or other personal payment is provided by Nestlé). He has no share options or other conflicts., (© 2024 The Authors. Published by Elsevier B.V.)
- Published
- 2024
- Full Text
- View/download PDF